PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 2 filers reported holding PTC THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $264 | +1289.5% | 11,800 | +2437.6% | 0.12% | +1060.0% |
| Q2 2023 | $19 | -91.9% | 465 | -92.4% | 0.01% | -93.7% |
| Q4 2022 | $234 | -99.8% | 6,132 | +106.5% | 0.16% | -50.0% |
| Q2 2022 | $118,000 | +76.1% | 2,969 | +124.9% | 0.32% | +310.4% |
| Q3 2021 | $67,000 | -94.4% | 1,320 | -95.0% | 0.08% | -83.0% |
| Q2 2020 | $1,197,000 | +2502.2% | 26,434 | +2471.4% | 0.45% | +502.7% |
| Q1 2020 | $46,000 | -40.3% | 1,028 | -36.3% | 0.08% | -15.7% |
| Q4 2019 | $77,000 | -93.2% | 1,613 | -93.6% | 0.09% | -86.0% |
| Q2 2019 | $1,130,000 | – | 25,114 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |